 Receptors, Nicotinic
"Receptors, Nicotinic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors.
| Descriptor ID |
D011978
|
| MeSH Number(s) |
D12.776.157.530.400.400.100.500 D12.776.543.550.425.500.100.500 D12.776.543.585.400.500.100.500 D12.776.543.750.051.687 D12.776.543.750.720.360.550
|
| Concept/Terms |
Receptors, Nicotinic- Receptors, Nicotinic
- Nicotinic Acetylcholine Receptors
- Acetylcholine Receptors, Nicotinic
- Receptors, Nicotinic Acetylcholine
- Nicotinic Receptors
- Nicotinic Acetylcholine Receptor
- Acetylcholine Receptor, Nicotinic
- Receptor, Nicotinic Acetylcholine
- Nicotinic Receptor
- Receptor, Nicotinic
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Nicotinic".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Carrier Proteins [D12.776.157]
- Membrane Transport Proteins [D12.776.157.530]
- Ion Channels [D12.776.157.530.400]
- Ligand-Gated Ion Channels [D12.776.157.530.400.400]
- Cysteine Loop Ligand-Gated Ion Channel Receptors [D12.776.157.530.400.400.100]
- Receptors, Nicotinic [D12.776.157.530.400.400.100.500]
- Membrane Proteins [D12.776.543]
- Membrane Glycoproteins [D12.776.543.550]
- Ion Channels [D12.776.543.550.425]
- Ligand-Gated Ion Channels [D12.776.543.550.425.500]
- Cysteine Loop Ligand-Gated Ion Channel Receptors [D12.776.543.550.425.500.100]
- Receptors, Nicotinic [D12.776.543.550.425.500.100.500]
- Membrane Transport Proteins [D12.776.543.585]
- Ion Channels [D12.776.543.585.400]
- Ligand-Gated Ion Channels [D12.776.543.585.400.500]
- Cysteine Loop Ligand-Gated Ion Channel Receptors [D12.776.543.585.400.500.100]
- Receptors, Nicotinic [D12.776.543.585.400.500.100.500]
- Receptors, Cell Surface [D12.776.543.750]
- Cysteine Loop Ligand-Gated Ion Channel Receptors [D12.776.543.750.051]
- Receptors, Nicotinic [D12.776.543.750.051.687]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Cholinergic [D12.776.543.750.720.360]
- Receptors, Nicotinic [D12.776.543.750.720.360.550]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Nicotinic".
This graph shows the total number of publications written about "Receptors, Nicotinic" by people in UAMS Profiles by year, and whether "Receptors, Nicotinic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 1 | 0 | 1 | | 2018 | 0 | 1 | 1 | | 2015 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2013 | 2 | 0 | 2 | | 2012 | 1 | 2 | 3 | | 2011 | 4 | 1 | 5 | | 2010 | 4 | 2 | 6 | | 2009 | 5 | 2 | 7 | | 2008 | 4 | 0 | 4 | | 2007 | 6 | 1 | 7 | | 2006 | 9 | 2 | 11 | | 2005 | 6 | 3 | 9 | | 2004 | 2 | 0 | 2 | | 2003 | 4 | 0 | 4 | | 2002 | 2 | 0 | 2 | | 2001 | 5 | 0 | 5 | | 2000 | 1 | 0 | 1 | | 1999 | 3 | 0 | 3 | | 1998 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 1994 | 1 | 0 | 1 | | 1992 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Nicotinic" by people in Profiles over the past ten years.
-
Bhandari D, Kachhap S, Madhukar G, Adepu KK, Anishkin A, Chen JR, Chintapalli SV. Exploring GPR109A Receptor Interaction with Hippuric Acid Using MD Simulations and CD Spectroscopy. Int J Mol Sci. 2022 Nov 26; 23(23).
-
Maggio SE, Saunders MA, Baxter TA, Nixon K, Prendergast MA, Zheng G, Crooks P, Dwoskin LP, Slack RD, Newman AH, Bell RL, Bardo MT. Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats. Psychopharmacology (Berl). 2018 05; 235(5):1439-1453.
-
Beckmann JS, Meyer AC, Pivavarchyk M, Horton DB, Zheng G, Smith AM, Wooters TE, McIntosh JM, Crooks PA, Bardo MT, Dwoskin LP. r-bPiDI, an a6ß2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement. Neurochem Res. 2015 Oct; 40(10):2121-30.
-
Crooks PA, Bardo MT, Dwoskin LP. Nicotinic receptor antagonists as treatments for nicotine abuse. Adv Pharmacol. 2014; 69:513-51.
-
Rahman MA, Masuda A, Ohe K, Ito M, Hutchinson DO, Mayeda A, Engel AG, Ohno K. HnRNP L and hnRNP LL antagonistically modulate PTB-mediated splicing suppression of CHRNA1 pre-mRNA. Sci Rep. 2013 Oct 14; 3:2931.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|